Axis Capital Limited analyst Kunal Randeria downgraded Glenmark Pharmaceuticals Ltd. (GNP:IN) from Buy (1) to Add (2) with a price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE